About the BOTOX^® Dreams Campaign

Many people living with cervical dystonia (CD) speak about the sense of new possibility they experience in their lives once they are successfully diagnosed and treated.

The BOTOX^® Dreams campaign, sponsored by Allergan, Inc. is a national health education and philanthropic campaign established to recognize people who are living with the challenges of cervical dystonia and wish to give back to their community.

Patients living with CD are invited to submit an essay describing their struggle with the condition and what treatment with BOTOX^® (Botulinum Toxin Type A) has meant to them. A panel of judges including Rem Murray, leading neurologists and representatives from patient advocacy organizations will select four CD patients, representing four U.S. regions, and Allergan will provide grants of $10,000 each to fulfill the philanthropic "wish" of four CD patients. The "wish" is to provide a service and/or additional resources to a philanthropic and community-focused program of their choice, such as community libraries, senior centers, police and fire departments, or other service and/or charitable organizations. By sharing their stories and "wishes" publicly, these patients will help raise awareness of CD, its impact on one's life and encourage earlier diagnosis and treatment.

About BOTOX^® (Botulinum Toxin Type A)

BOTOX^® is approved for the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia.

Important Safety Information

Who Should Not Be Treated With BOTOX^®

BOTOX^® treatment is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation.

Warnings

Serious heart problems and serious allergic reactions have been reported rarely. If you think you're having an allergic reactions or other unusual symptoms, such as difficulty swallowing, speaking, or breathing, call your doctor immediately.

Patients with certain neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious side effects.

Patients with neuromuscular disorders may be at increased risk of clinically significant systemic effects including severe dysphagia (difficulty swallowing) and respiratory compromise from typical doses of BOTOX^®.

Dysphagia (difficulty swallowing) is a commonly reported adverse event following treatment of cervical dystonia patients with all botulinum toxins. In these patients, there are reports of rare cases of dysphagia severe enough to warrant the insertion of a gastric feeding tube.

Precautions

Patients or caregivers should be advised to seek immediate medical attention if swallowing, speech, or respiratory disorders arise.

Side Effects

Localized pain, tenderness, and/or bruising may be associated with the injection.

In cervical dystonia, the most common side effects following injection include difficulty swallowing (19%), upper respiratory infection (12%), neck pain (11%), and headache (11%).

Click here for full prescribing information for BOTOX^®

About the BOTOX® Dreams Campaign